AI-generated analysis. Always verify with the original filing.
Basel Medical Group Ltd announced on March 24, 2026, that Nasdaq has determined compliance with the periodic filing requirement under Listing Rule 5250(c)(1) based on the company's amended annual report on Form 20-F for fiscal year 2025, filed with the SEC on March 13, 2026. This resolves the prior deficiency relating to the Periodic Filing Rule.